Effect of zinc supplementation on glycemic biomarkers: an umbrella of interventional meta-analyses.

ABSTRACT

BACKGROUND: Several studies have evaluated the effects of zinc supplementation on glycemic biomarkers in humans and have demonstrated varying results. We systematically evaluated the literature and performed an umbrella meta-analysis of the effects of zinc supplementation on type 2 diabetes biomarkers. METHODS: A comprehensive literature search was conducted in the following databases; PubMed, Embase, Embase, Cochrane Library, Scopus, and Web of Science for studies published up to March 10, 2024. RESULTS: Zinc supplementation was effective in reducing serum FBS (WMD - 13.58, 95% CI - 17.38, - 9.77; p < 0.001; SMD - 0.52, 95% CI - 0.79, - 0.25; p = < 0.001), insulin (SMD - 0.67, 95% CI - 0.96, - 0.38; p < 0.001), HOMA-IR levels (WMD - 0.52, 95% CI - 0.66, - 0.38; p < 0.001; SMD - 0.78, 95% CI - 1.02, - 0.42; p < 0.001), and HbA1c (WMD - 0.35, 95% CI - 0.43, - 0.27; p < 0.001). CONCLUSION: Zinc supplementation significantly reduced FBS, HOMA-IR, insulin and HbA1c. These findings suggest that zinc is potentially an effective complementary intervention to improve type 2 diabetes biomarkers.